Latest News

FDA grants Novavax COVID-19 vaccine full approval for high risk groups / image credit ©Waldenmarus/stock.adobe.com
FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups

May 20th 2025

Nuvaxovid (NVX-CoV2373) is indicated for those aged ≥65 years and aged 12 to 64 years with at least one condition that puts them at high risk for severe infection.

 One in 5 US Adults Chooses Against Handwashing, Some Citing it as "Unnecessary," National Survey Finds / image credit ©F/stock.adobe.com
One in 5 US Adults Chooses Against Handwashing, Some Citing it as "Unnecessary," National Survey Finds

May 5th 2025

Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose / image credit: ©New Africa/AdobeStock
Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose

April 28th 2025

Endemic Measles is a Clear and Present Danger, According to Stanford University Modeling Study  / image credit ©ขวัญฤทัย เฉลาชาญชัยย/stock.adobe.com (Generated via AI)
Endemic Measles is a Clear and Present Danger, According to Stanford University Modeling Study

April 25th 2025

Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial
Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial

April 15th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.